Overview
Venus Concept Q2 revenue of $15.7 mln beats analyst expectations, per LSEG data
Net income and EPS for Q2 missed analyst expectations, per LSEG data
Co announced sale of Venus Hair business for $20 mln to focus on core operations
Outlook
Company not providing financial guidance for fiscal year 2025
Result Drivers
U.S. REVENUE GROWTH - U.S. revenue increased by 5% year-over-year, driven by a 23% rise in cash systems sales
INTERNATIONAL REVENUE DECLINE - International revenue decreased by 18% year-over-year, attributed to customer uncertainty about economic stability and tighter third-party lending practices
COST MANAGEMENT - Co focused on managing cash burn through disciplined cost management and targeted investments to support long-term growth, per CEO Rajiv De Silva
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $15.70 mln | $14.60 mln (2 Analysts) |
Q2 EPS | Miss | -$8.03 | -$6.54 (2 Analysts) |
Q2 Net Income | Miss | -$11.70 mln | -$9.39 mln (2 Analysts) |
Q2 Adjusted EBITDA |
| -$8.80 mln |
|
Q2 Gross Margin |
| 60.1% |
|
Q2 Operating Income | Miss | -$9 mln | -$8.25 mln (2 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."
Press Release: ID:nGNX8hV6LW